Literature DB >> 9849307

Early treatment of rheumatoid arthritis: rationale, evidence, and implications.

L B van de Putte1, A M van Gestel, P L van Riel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9849307      PMCID： PMC1752733          DOI： 10.1136/ard.57.9.511

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

1.  Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy.

Authors:  T Möttönen; L Paimela; J Ahonen; T Helve; P Hannonen; M Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  1996-06

Review 2.  Biologic agents for the treatment of rheumatoid arthritis.

Authors:  V Strand; E Keystone; F Breedveld
Journal:  Rheum Dis Clin North Am       Date:  1996-02       Impact factor: 2.670

Review 3.  Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).

Authors:  A M van Gestel; C J Haagsma; D E Furst; P L van Riel
Journal:  Baillieres Clin Rheumatol       Date:  1997-02

Review 4.  Biologic agents for treating rheumatoid arthritis. Concepts and progress.

Authors:  L W Moreland; L W Heck; W J Koopman
Journal:  Arthritis Rheum       Date:  1997-03

Review 5.  The epidemiology of drug treatment failure in rheumatoid arthritis.

Authors:  F Wolfe
Journal:  Baillieres Clin Rheumatol       Date:  1995-11

Review 6.  Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

Authors:  L Iannuzzi; N Dawson; N Zein; I Kushner
Journal:  N Engl J Med       Date:  1983-10-27       Impact factor: 91.245

Review 7.  Natural remission in inflammatory polyarthritis: issues of definition and prediction.

Authors:  B J Harrison; D P Symmons; P Brennan; E M Barrett; A J Silman
Journal:  Br J Rheumatol       Date:  1996-11

8.  Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

Authors:  G Borg; E Allander; B Lund; E Berg; U Brodin; H Pettersson; L Trang
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

9.  Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

Authors:  C Egsmose; B Lund; G Borg; H Pettersson; E Berg; U Brodin; L Trang
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

10.  Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.

Authors:  L A Joosten; M M Helsen; F A van de Loo; W B van den Berg
Journal:  Arthritis Rheum       Date:  1996-05
View more
  5 in total

1.  Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis.

Authors:  J M Albers; L Paimela; P Kurki; K B Eberhardt; P Emery; M A van 't Hof; F H Schreuder; M Leirisalo-Repo; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

2.  A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis.

Authors:  Manas Talukdar; Gopinath Barui; Anjan Adhikari; Rupam Karmakar; Udas Chandra Ghosh; Tushar Kanti Das
Journal:  J Clin Diagn Res       Date:  2017-01-01

3.  No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.

Authors:  E J Kroot; M A van Leeuwen; M H van Rijswijk; M L Prevoo; M A Van 't Hof; L B van De Putte; P L van Riel
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

4.  Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Authors:  Maria L E Andersson; Kristina Forslind; Ingiäld Hafström
Journal:  Open Rheumatol J       Date:  2015-02-03

5.  The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Mihail Virgil Boldeanu; Manole Cojocaru; Viorel Biciuşcă; Vlad Pădureanu; Maria Bogdan; Ramona Georgiana Badea; Carmen Avramescu; Ileana Octavia Petrescu; Florin Petrescu; Cristian A Siloşi
Journal:  J Immunol Res       Date:  2016-08-04       Impact factor: 4.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.